G A Gudelsky
Overview
Explore the profile of G A Gudelsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
976
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schaefer T, Grace C, Gudelsky G, Vorhees C, Williams M
Stress
. 2010 Jul;
13(6):469-80.
PMID: 20666642
Methamphetamine (MA) induces multiple effects in rats including alterations to corticosterone (CORT) and adrenocorticotropic hormone (ACTH). This effect is age dependent showing a U-shaped function similar to that of other...
2.
Straiko M, Coolen L, Zemlan F, Gudelsky G
Neuroscience
. 2006 Nov;
144(1):223-31.
PMID: 17084036
The present study quantified the cleaved form of the microtubule-associated protein tau (cleaved MAP-tau, C-tau), a previously demonstrated marker of CNS toxicity, following the administration of monoamine-depleting regimens of the...
3.
Ehrman L, Williams M, Schaefer T, Gudelsky G, Reed T, Fienberg A, et al.
Genes Brain Behav
. 2006 Oct;
5(7):540-51.
PMID: 17010100
Mice lacking phosphodiesterase 1B (PDE1B) exhibit an exaggerated locomotor response to D-methamphetamine and increased in vitro phosphorylation of DARPP32 (dopamine- and cAMP-regulated phosphoprotein, M r 32 kDa) at Thr34 in...
4.
Straiko M, Gudelsky G, Coolen L, Harrison R, Zemlan F
J Neurosci Res
. 2006 Aug;
84(5):1116-23.
PMID: 16917841
Trimethyltin (TMT) is a well-documented neurotoxin that affects primarily limbic system structures. Most previous studies have relied on histological approaches to examine TMT neurotoxicity, so the aim of this study...
5.
Nair S, Gudelsky G
Brain Res Bull
. 2006 Apr;
69(4):382-7.
PMID: 16624669
The amphetamine analog 3,4-methylenedioxymethamphetamine (MDMA) is considered to be selectively neurotoxic to serotonergic nerve terminals. Although the long term effects of MDMA on serotonin (5-HT) terminals have been well studied,...
6.
Zemlan F, Mulchahey J, Gudelsky G
Neuroscience
. 2003 Oct;
121(2):399-409.
PMID: 14521998
Previous studies of neuronal degeneration induced by the neurotoxin, kainic acid, employed silver stain techniques that are non-quantitative or ELISA measurement of the non-neuronal protein, glial fibrillary acidic protein. As...
7.
Wallace T, Vorhees C, Zemlan F, Gudelsky G
Neuroscience
. 2003 Mar;
116(4):1063-8.
PMID: 12617947
The view that methamphetamine is neurotoxic to dopaminergic and serotonergic axon terminals has been based largely on biochemical and histological studies. In the present study, methamphetamine-induced structural damage to axons...
8.
Morford L, Gudelsky G, Williams M, Vorhees C
Eur J Neurosci
. 2002 Aug;
16(3):491-500.
PMID: 12193193
D-Fenfluramine, a serotonin releaser, was administered to neonatal rats on postnatal days 11-20 (a stage of hippocampal development analogous to third trimester human ontogeny). As adults, the D-fenfluramine-treated offspring exhibited...
9.
Nixdorf W, Burrows K, Gudelsky G, Yamamoto B
J Neurochem
. 2001 Apr;
77(2):647-54.
PMID: 11299327
The acute and long-term effects of the local perfusion of 3,4-methylenedioxymethamphetamine (MDMA) and the interaction with the mitochondrial inhibitor malonate (MAL) were examined in the rat striatum. MDMA, MAL or...
10.
Wallace T, Gudelsky G, Vorhees C
Psychopharmacology (Berl)
. 2001 Mar;
153(3):321-6.
PMID: 11271404
Rationale: The long-term neurochemical effects produced by the repeated administration of methamphetamine (MA) and 3,4-methylenedioxymethamphetamine (MDMA) are well documented; however, the functional consequences have not been clearly defined. Objective: The...